Medical Device & Technology

Rowan University and NJEDA launch a Strategic Innovation Center to boost medical device investments and accelerate medtech innovation in South Jersey.

Cardiosense's CardioTag gains FDA clearance, advancing cardiac monitoring with wearable technology for personalized, noninvasive heart health insights.

CMS establishes a national payment for AI ECG analysis, paving the way for enhanced cardiovascular diagnostics and early patient intervention.

RenovoRx launches the PanTheR study to evaluate the RenovoCath device's long-term safety and effectiveness in treating solid tumors, advancing cancer care.

Edwards Lifesciences reports robust Q2 growth, raises 2025 guidance, driven by strong TAVR and TMTT sales, enhancing its market leadership.

MeMed BV Flex could revolutionize infection diagnosis, enabling rapid differentiation between bacterial and viral infections in just 15 minutes with a fingerstick test.

FDA's AI tool, Elsa, faces scrutiny for producing unreliable data, raising concerns about its rapid implementation and impact on regulatory accuracy.

GE HealthCare leads in FDA AI-enabled medical device authorizations, showcasing innovation in imaging and diagnostics to enhance patient care and streamline workflows.

Digital asthma program shows sustained benefits in landmark clinical trial

New 154,000-square-foot Class A facility aims to address the growing demand for purpose-built life sciences manufacturing infrastructure.

Independent practices say EHRs lead the way — but telehealth, patient portals and analytics tools are driving measurable results, especially in mental health care.

Proximie and HistoSonics collaborate to enhance non-invasive liver tumor treatments, improving patient outcomes and surgical efficiency through advanced technology integration.

Caranx Medical's AI software advances TAVI procedures, enhancing precision and accessibility for heart valve surgeries, improving patient outcomes.

iFIT and Samsung Health unite to deliver personalized fitness experiences through Galaxy devices, enhancing wellness with AI-driven insights and interactive content.

A flexible new wristband developed by engineers at the University of California San Diego could improve how people with diabetes manage their health by continuously monitoring glucose and key cardiovascular signals in real time.

Bruin Biometrics CEO Martin Burns discusses the "formulas" that guided the company through the challenges of bringing a device to market.

SK Capital partners with LISI Group to acquire Lisi Medical, enhancing its presence in the life sciences CDMO sector and driving future growth.

New Moneypenny survey shows two-thirds of health care organizations are now using or exploring AI, but concerns over data security, implementation and patient experience remain.

ArteraAI Prostate advances prostate cancer treatment with AI-driven insights, enhancing risk assessment and personalizing care for better patient outcomes.

In a wide-ranging interview, Martin Burns discusses Bruin Biometrics’ Provizio SEM Scanner, why diagnostic and prevention tech innovation is underfunded and the challenges and opportunities facing the MedTech industry.

TEAM Technologies enhances its medical device manufacturing capabilities by acquiring Duke Empirical, positioning itself for growth in the cardiovascular sector.

System integrates handheld robotics, real-time ultrasound, and advanced software to help clinicians consistently and accurately place needles during procedures like organ access, biopsies, vascular access, and therapy delivery.

In a wide-ranging interview, Martin Burns discusses Bruin Biometrics’ Provizio SEM Scanner, why diagnostic and prevention tech innovation is underfunded and the challenges and opportunities facing the MedTech industry.

Hider comes from ATS Corp., an automation solutions company

Wristband delivers personalized, adaptive stimulation throughout the day without the need for surgery or drugs